Huakang Biomedical Holdings Co Ltd (HKSE:08622) Share Price

Company Profile

Business description
Joyzyme Group Ltd, formerly Huakang Biomedical Holdings Co Ltd is engaged in the research, development, manufacture, marketing, and sale of in-vitro diagnostic reagents and auxiliary reproductive supplies and equipment in China. Its products include Male fertility IVD reagents; Parasite antibody detection reagents, EBV antibody detection reagents, and Auxiliary reproductive supplies and equipment. The group has also diversified its business to vitamins and supplements products for the markets in the PRC, Hong Kong, and Canada. The company derives maximum revenue from PRC.
Contact
No.16 Yinkui Road
1-3 floor and 5th floor, Building D, Shenzhen Junxuan
Kui Xin Community, Kui Chong Office
Dapeng New District
Shenzhen
CHN
T: +86 75533853878
https://joyzymebiotech.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
98

Recommended

Our thesis remains unchanged.

Roy Van Keulen | 04 February 2026

AMD has the components to target $100 billion of AI revenue in the next few years.

Brian Colello, CPA | 04 February 2026

We expect to lower our fair value estimate of PayPal stock.

Brett Horn, CFA | 03 February 2026

Index	Last price	Change	% Change
All Ordinaries	9,154.90	26.00	-0.28%
CAC 40	8,282.61	20.45	0.25%
DAX 40	24,563.21	39.83	-0.16%
Dow JONES (US)	49,501.30	260.31	0.53%
FTSE 100	10,363.72	38.62	-0.37%
HKSE	26,885.24	37.92	0.14%
NASDAQ	22,904.58	350.61	-1.51%
Nikkei 225	53,818.04	475.32	-0.88%
NZX 50 Index	13,444.02	23.27	-0.17%
S&P 500	6,882.72	35.09	-0.51%
S&P/ASX 200	8,889.20	14.80	-0.17%
SSE Composite Index	4,075.92	26.29	-0.64%